1. Home
  2. ATYR vs DIT Comparison

ATYR vs DIT Comparison

Compare ATYR & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.88

Market Cap

69.2M

Sector

Health Care

ML Signal

HOLD

Logo AMCON Distributing Company

DIT

AMCON Distributing Company

N/A

Current Price

$112.99

Market Cap

70.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
ATYR
DIT
Founded
2005
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Food Distributors
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
69.2M
70.9M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
ATYR
DIT
Price
$0.88
$112.99
Analyst Decision
Hold
Analyst Count
8
0
Target Price
$4.20
N/A
AVG Volume (30 Days)
2.5M
1.3K
Earning Date
03-12-2026
01-19-2026
Dividend Yield
N/A
0.89%
EPS Growth
N/A
N/A
EPS
N/A
1.63
Revenue
$190,000.00
$2,273,870,361.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18,728.88
N/A
P/E Ratio
N/A
$69.19
Revenue Growth
N/A
3.24
52 Week Low
$0.64
$94.92
52 Week High
$7.29
$145.00

Technical Indicators

Market Signals
Indicator
ATYR
DIT
Relative Strength Index (RSI) 54.93 55.77
Support Level $0.82 $108.20
Resistance Level $0.94 $113.85
Average True Range (ATR) 0.10 2.33
MACD 0.01 0.67
Stochastic Oscillator 54.37 86.70

Price Performance

Historical Comparison
ATYR
DIT

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

Share on Social Networks: